Showing results (2911-2920 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 27, 2002
Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in SwedenFrances B Garfield, Denis Getsios, J Jaime Caro, et al.Pharmacoeconomics|August 31, 2002
Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal CancerMike Aristides, Jack Chen, Mark Schulz, et al.Pharmacoeconomics|May 8, 2002
Economic considerations related to providing adequate pain relief for women in labour: comparison of epidural and intravenous analgesiaCecil Huang, Alex MacarioPharmacoeconomics|May 8, 2002
The practice of splitting tablets: cost and therapeutic aspectsJohn Bachynsky, Cheryl Wiens, Krystal MelnychukPharmacoeconomics|May 8, 2002
The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in SwedenLars Agréus, Lars BorgquistPharmacoeconomics|May 31, 2002
The role of models within economic analysis: focus on type 2 diabetes mellitusDouglas Coyle, Karen M Lee, Bernie J O'BrienPharmacoeconomics|February 26, 2003
Ontario's formulary committee: how recommendations are madeAnne M PausJenssen, Peter A Singer, Allan S DetskyPharmacoeconomics|October 31, 2002
Theoretical arguments for the discounting of health consequences: where do we go from here?Angelina LazaroPharmacoeconomics|October 31, 2002
Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndromeMax Brosa, Carlos Rubio-Terrés, Ibrahim Farr, et al.Pharmacoeconomics|July 12, 2002
Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistanceJoseph L Kuti, Blair Capitano, David P NicolauPageof 336